Highlights
NASDAQ: ADXS       Advaxis Inc
Last Price Today's Change   Day's Range   Trading Volume
0.472   0.00 (0.00%)  0.00 - 0.00  0

Overview

 
Avg Volume (4 weeks):4,599,189
4 Weeks Range:0.44 - 0.825
4 Weeks Price Volatility (%):
57.21%
52 Weeks Range:0.264 - 1.57
52 Weeks Price Volatility (%):
30.06%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Advaxis Inc is a clinical stage biotechnology company operating in the United States. It focuses on discovery, development, and commercialization of proprietary Lm (Listeria monocytogenes)-LLO (Listeriolysin O) cancer immunotherapies. These immunotherapies are based on a platform technology which utilizes live attenuated Listeria monocytogenes (Lm) bioengineered to secrete antigen/adjuvant fusion proteins. The company’s immunotherapy products based on Lm-LLO immunotherapy are Axalimogene filolisbac (AXAL) which targets Human Papilloma Virus (HPV) - associated cancers and ADXS-PSA which targets Prostate Specific Antigen (PSA) associated with prostate cancer.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

10437 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 KSMT 9.900.00 
 HIPS 14.920.00 
 HONE 14.660.00 
 ENZL 64.120.00 
 KOD 117.480.00 
 UPRO 104.180.00 
 COLD 39.160.00 
 ALYA 2.150.00 
 CIGI 103.060.00 
 AXNX 61.950.00 

TOP ARTICLES

1. CryptoNews of the Week CryptoNews
2. Equities Dipped Further on Virus Resurgence State of The Markets
3. Wall Street Breakfast: Coming Of Age? Wall Street Breakfast
4. Daily Futures Trading Strategy 22 April 2021 Where Futures Lies
5. Bulls Took A Breather Amid Profit Taking State of The Markets